Patil Neena M sold 1,200 Jazz Pharmaceuticals shares at $240.94 each on Sept. 10, leaving her with 47,671 shares. The sale represented about 2.5% of her prior holding, giving investors the disclosed size of the transaction and the executive’s remaining position.

Key Highlights

  • Jazz Pharmaceuticals identifies Patil Neena M as its EVP and chief legal officer.
  • SEC transaction code S classifies the activity as an open-market sale.
  • The transaction represented about 2.5% of Patil Neena M’s prior shares holding.

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) executive Patil Neena M sold 1,200 shares at $240.94 per share on 10 September 2026, leaving her with 47,671 shares. The transaction represented about 2.5% of her prior shares holding.

$240.94 Per-Share Sale Recorded

Patil Neena M’s transaction involved 1,200 Jazz Pharmaceuticals plc shares at $240.94 per share. The transaction date was 10 September 2026. The reported price applies to each share involved in the transaction.

Post-Transaction Holding Stands at 47,671 Shares

Following the transaction, her reported ownership of Jazz Pharmaceuticals plc stood at 47,671 shares. The percentage uses the prior holding as its reference, while 47,671 shares represents the stated position after the transaction. The disclosed figures show both the transaction’s proportion and the remaining ownership balance.